What You Should Know:
– Proscia, a pathology AI company, has announced the next step in its collaboration with Amazon Web Services (AWS) to address two of digital pathology’s most pressing challenges: managing surging data…
Continue Reading
Top News
The FDA grants clearance for the upgraded cardiac imaging platform of precision medicine vendor Tempus AI, sending the company’s shares up 14% on Thursday to reach a market cap of $15…
Continue Reading
What You Should Know:
– DNAnexus, Inc., a global provider of a leading enterprise platform for precision health data, has announced its intention to bring precision medicine capabilities to select Oracle Health clinical applications.
– The…
Continue Reading
What You Should Know:
– Proscia®, a pathology AI company, has announced the launch of Proscia Aperture™, a new precision medicine solution designed to automatically identify eligible patients for clinical trials at the moment of…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Ronen Veksler, Co-Founder and CEO at Promise Bio. Promise Bio is an…
Continue Reading
Professor Dragan Primorac, M.D., Ph.D
Personalized medicine, also known as precision medicine, is redefining healthcare by tailoring medical treatment to the unique characteristics of each individual. This approach integrates genetic, environmental, and lifestyle factors to…
Continue Reading
What You Should Know:
– Tempus AI, Inc., a technology company focused on advancing precision medicine with AI, has acquired Paige, an AI company specializing in digital pathology.
– The acquisition, valued at $81.25M, paid predominantly…
Continue Reading
Market Overview and Size Projections
The Global Value-Based Healthcare Market is experiencing unprecedented transformation as healthcare systems worldwide prioritize quality, cost-effectiveness, and patient outcomes over traditional volume-based models. This paradigm shift represents a fundamental change…
What You Should Know:
– Mayo Clinic announced a pivotal step toward integrating AI solutions in the clinical setting with the deployment of NVIDIA DGX SuperPOD with NVIDIA DGX B200 systems.
– The advanced infrastructure provides…
Continue Reading
Rameez Chatni, Global Director AI Solutions—Pharmaceutical and Life Sciences at Cloudera
As precision medicine continues to reshape the future of healthcare, clinical trials are evolving from one-size-fits-all studies into highly targeted investigations driven by genomics…
Continue Reading
